- Research category
- Longevity & Metabolic
- Format
- Lyophilized peptide material
- Purity spec
- Greater than 99%
- Availability
- Approved accounts
- Documentation
- COA coming soon
Certificate of Analysis coming soon
Longevity & Metabolic
AOD-9604
Fragment of human growth hormone targeting fat metabolism. The compendium positions it as a body-composition finisher after primary weight-loss protocols, particularly for stubborn visceral or abdominal fat research. Mechanism: Stimulates lipolysis and inhibits lipogenesis without affecting blood sugar or raising IGF-1, unlike full HGH.
- Availability
- Wholesale Access Only
AOD-9604 · Research use only
Research context
Stubborn fat after primary weight loss; visceral and abdominal fat reduction; menopausal fat redistribution; body composition post-GLP-1 protocol.
Material information
- Grade
- Research Use Only (RUO)
- Format
- Lyophilized peptide material
- Purity
- Greater than 99%
- Appearance
- Lyophilized powder
Documentation
Batch-specific documentation may be available for approved account review. View documentation standards.
Regulatory status
For laboratory research use only. Not for human consumption, diagnosis, treatment, cure, or prevention of disease.
Restrictions
Research use only
This material is offered for research use only. Not for human or animal use. Not intended for clinical, diagnostic, therapeutic, veterinary, or personal use. PeptaPharma does not provide dosing, administration, or treatment guidance.
Related materials
Synthesized & tested in the United States.
PeptaPharma materials are produced and analytically tested in U.S. facilities. Batch-level documentation and Certificates of Analysis accompany each lot for approved-account review.